The EZH2 inhibitor EZH2i blocks proliferation in EZH2 mutant DLBCL cell lines [73], and even in EZH2 wild-type lymphoma cells [29,31,74]. The gene discussed is EZH2; the disease is diffuse large B-cell lymphoma.